♟️ Thursday 12 February 2026 Thu, 12 Feb 2026

Bannerman Energy has secured a landmark $321.5 million strategic investment from CNNC Overseas Limited to jointly develop the Etango Uranium Project in Namibia, enabling debt-free construction and a market-priced offtake agreement with a Tier-1 nuclear utility.

Northern Star Resources has reported a robust half-year result with a 41% jump in net profit, driven by soaring gold prices despite operational setbacks. The company also announced a fully franked interim dividend of 25 cents per share.

Podium Minerals has disclosed the initial securities interests of its newly appointed directors, highlighting a significant allocation of performance rights to Gary Humphries while Neal Froneman holds none.

Invex Therapeutics reports a net loss of $715,582 for H1 2026 while advancing its Exenatide program targeting neurological diseases, alongside notable board reshuffles.

Cobre Limited has secured A$60 million to acquire a majority stake in the Sierra Atacama Copper Project in Chile, positioning itself as a significant copper producer with strong expansion potential.

US1 Critical Minerals has provided clarity on the issuance of 50 million fee options to consultants related to its December 2025 placement, reaffirming shareholder approval is pending and no funds will be raised from this issuance.

Savana Asset Management highlights the US as the leading global equity market, driven by robust economic growth, AI investment surges, and investor-friendly policies. Their insights reveal why Australian investors might look across the Pacific for growth opportunities.

Paladin Energy reported a 16% increase in uranium production and a significant rise in sales volumes for the December 2025 quarter, alongside a successful equity raise and debt restructuring that enhance its financial flexibility.

Peel Mining has agreed to sell its South Cobar Copper Project to Aeris Resources in a $214 million transaction, while spinning off its remaining assets into a new ASX-listed company, NewCo. The deal offers Peel shareholders immediate value and ongoing exposure to a diversified metals portfolio.

Pro Medicus has reported its strongest half-year performance yet, with revenue and profits surging alongside a wave of new multi-million dollar contracts and strategic AI investments. The healthcare IT leader is expanding its global footprint and cloud capabilities, setting the stage for sustained growth.

Aeris Resources has announced a strategic all-scrip acquisition of Peel Mining, consolidating key copper assets in New South Wales and aiming to extend the Tritton mine life beyond a decade. Peel shareholders will also retain exposure to precious metals exploration through a demerger into a new ASX-listed entity.

Aeris Resources has agreed to acquire Peel Mining in a strategic deal that consolidates key copper assets and extends the Tritton mine life to over 10 years. Peel shareholders will receive Aeris shares plus stakes in a new ASX-listed entity holding Peel’s remaining exploration assets.

Elixinol Wellness reported a 9.5% revenue increase in Q4 FY25 alongside a 30% reduction in operating costs, setting a clear path to profitability under fresh executive leadership.

Paladin Energy reported a strong half-year performance with uranium sales revenue climbing to US$138.3 million, driven by ramp-up at its Namibian mine and significant progress on Canadian development projects.

ASX Limited reported robust first-half results with 11.2% revenue growth, while advancing a strategic reset in response to the ASIC Inquiry and pushing forward its technology modernization agenda.

ASX Limited reported robust half-year results with an 11.2% rise in operating revenue and a steady net profit, while advancing its technology upgrade and responding to regulatory scrutiny.

Pro Medicus Limited reported a robust half-year performance, with underlying profit after tax rising by approximately 30%, driven by significant new sales and strategic implementations. The company remains confident in its proprietary technology's resilience against AI disruption while expanding its market footprint.

ASX Limited has posted a solid 8.3% increase in net profit for the half-year ending December 2025, while announcing a reduced dividend payout and the planned departure of its CEO. The company is navigating regulatory scrutiny and investing heavily in technology upgrades.

Pro Medicus Limited has reported a stellar half-year performance with revenue up 28.4% and a surge in net profit, driven by major US contract wins and strategic investments.

OncoSil Medical’s CEO Nigel Lange has agreed to a 10% salary reduction, opting instead to receive shares at a significant premium, reinforcing executive commitment to shareholder value and cost discipline.

The US Department of Commerce has finalized hefty antidumping and countervailing duties on Chinese graphite active anode materials, a move expected to strengthen Syrah Resources’ competitive edge in North America and accelerate its US operations.

Axel REE is fast-tracking field recovery trials at its Caladão Project, leveraging proven in situ recovery methods and a rare gallium resource to position itself uniquely in the critical minerals space.

MFF Capital Investments reported a 45% drop in net profit for the half year to December 2025 but declared a higher fully franked dividend, marking a milestone in its operational independence and strategic growth.

Torque Metals reports a significant 20-metre intercept grading 5.8 grams per tonne gold at its Paris Gold Project, confirming the deposit as a multi-lode, high-grade system with strong growth potential.